PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-20.48%
Both yoy net incomes decline, with NXPI at -153.89%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-2.95%
Both reduce yoy D&A, with NXPI at -2.06%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-95.65%
Negative yoy deferred tax while NXPI stands at 11300.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
30.00%
SBC growth well above NXPI's 2.94%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-265.34%
Both reduce yoy usage, with NXPI at -22.26%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-169.06%
Both yoy AR lines negative, with NXPI at -157.14%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-81.82%
Both reduce yoy inventory, with NXPI at -96.30%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-460.00%
Both negative yoy AP, with NXPI at -100.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-400.00%
Negative yoy usage while NXPI is 129.20%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
96.35%
Lower 'other non-cash' growth vs. NXPI's 266.67%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-52.12%
Both yoy CFO lines are negative, with NXPI at -33.81%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
1.60%
Lower CapEx growth vs. NXPI's 29.91%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-100.00%
Both yoy lines negative, with NXPI at -1616.67%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
64.25%
Purchases growth of 64.25% while NXPI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
29.47%
Liquidation growth of 29.47% while NXPI is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
103.45%
Growth well above NXPI's 122.22%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
132.18%
We have mild expansions while NXPI is negative at -38.64%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment similar to NXPI's 98.68%. Walter Schloss sees parallel liability management or similar free cash flow availability.
75.71%
Issuance growth of 75.71% while NXPI is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
4.01%
Buyback growth below 50% of NXPI's 97.78%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.